Novazepra®
Tirzepatide
A once-weekly solution for injection
in a pre-filled pen.
-
Once
Weekly -
Pre-filled
Pen -
Subcutaneous
Use -
Clinically
Developed
Novazepra® is a prescription medicine. Use only as prescribed by your healthcare professional.
At GenomaLab, we believe that better metabolic health changes lives. Through innovative therapies, scientific integrity, and a commitment to quality, we strive to support healthcare professionals and empower patients across the Middle East, Africa, and beyond.
Trusted Across 28 Countries
Novazepra® is approved and marketed in 28 countries and is available throughout the Middle East and Africa through established regulatory pathways and local healthcare partnerships.
Our growing international footprint reflects the confidence placed in Novazepra® by healthcare professionals, regulatory authorities, and patients worldwide.
24/7
Regional Medical Support
Available Dose Range
How Novazepra® Works
Tirzepatide is a dual GIP and GLP-1 receptor agonist that helps improve glycaemic control and supports weight management when used alongside diet and exercise.
Manufactured to World-Class Standards
Novazepra® is manufactured in a world-class pharmaceutical facility operating in accordance with internationally recognized Good Manufacturing Practice (GMP) standards.
Every batch undergoes rigorous quality controls to ensure consistency, purity, safety, and reliability.
Our manufacturing partners adhere to strict quality systems designed to meet regulatory expectations and deliver products that healthcare professionals and patients can trust.
GMP Certified
🛡
Quality Assured
🌍
International Standards
📋
Batch Controlled
Support. Education. Confidence.
Patient Support
Injection guides, storage tips, FAQs and more.
Healthcare Professionals
Prescribing information, dosing, and resources.
Safety Information
Important safety information and side effect reporting.
Need Help?
Contact our team for medical or product enquiries.